Dominant negative mutations of the tumor suppressor CCAAT/enhancer binding protein α (C/EBP α):: Role in acute myeloid leukemia.

被引:0
|
作者
Pabst, T
Mueller, BU
Schnittger, S
Behre, G
Hiddemann, W
Tenen, DG
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA USA
[2] Univ Munich, Klinikum Grosshadern, Dept Med 3, D-8000 Munich, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2772
引用
收藏
页码:624A / 624A
页数:1
相关论文
共 50 条
  • [31] CCAAT/enhancer binding protein (C/EBP) beta regulates osteoblast and osteoclast differentiation
    Smink, J. J.
    Begay, V.
    Leutz, A.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S94 - S94
  • [32] Determining the CCAAT/enhancer binding protein β (C/EBPβ) partnership profile in gastric carcinogenesis
    Resende, C.
    Regalo, G.
    Seruca, R.
    Machado, J. C.
    HELICOBACTER, 2010, 15 (04) : 327 - 328
  • [33] Control of adipocyte differentiation by CCAAT/enhancer binding protein alpha (C/EBP alpha)
    Lane, MD
    Lin, FT
    MacDougald, OA
    VasseurCognet, M
    INTERNATIONAL JOURNAL OF OBESITY, 1996, 20 : S91 - S96
  • [34] CCAAT/enhancer binding protein δ (C/EBPδ) expression and elevation in Alzheimer's disease
    Li, RN
    Strohmeyer, R
    Liang, Z
    Lue, LF
    Rogers, J
    NEUROBIOLOGY OF AGING, 2004, 25 (08) : 991 - 999
  • [35] CCAAT enhancer binding protein gamma (C/EBP-γ): An understudied transcription factor
    Renfro, Zachary
    White, Bryan E.
    Stephens, Kimberly E.
    ADVANCES IN BIOLOGICAL REGULATION, 2022, 84
  • [36] The role of RUNX1 DNA-Binding mutations in acute myeloid leukemia.
    Cammenga, J
    Putz, G
    Niebuhr, B
    Horn, S
    Bergholz, U
    Buchholz, F
    Stocking, C
    BLOOD, 2005, 106 (11) : 397A - 398A
  • [37] Inhibition of collagen gene expression by interferon-γ:: Novel role of the CCAAT/enhancer binding protein β (C/EBPβ)
    Ghosh, AK
    Bhattacharyya, S
    Mori, Y
    Varga, J
    JOURNAL OF CELLULAR PHYSIOLOGY, 2006, 207 (01) : 251 - 260
  • [38] Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein α in myelodysplastic syndromes and acute myeloid leukemias
    Gombart, AF
    Hofmann, WK
    Kawano, S
    Takeuchi, S
    Krug, U
    Kwok, SH
    Larsen, RJ
    Asou, H
    Miller, CW
    Hoelzer, D
    Koeffler, HP
    BLOOD, 2002, 99 (04) : 1332 - 1340
  • [39] Epigenetic modulation of tumor suppressor CCAAT/Enhancer binding protein a activity in lung cancer
    Tada, T
    Brena, RMT
    Hackanson, B
    Morrison, C
    Otterson, GA
    Plass, C
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (06): : 396 - 406
  • [40] CCAAT enhancer binding protein-α (C/EBPα) determines myeloid versus erythroid cell fate in multipotential progenitors.
    Suh, HC
    Gooya, J
    Renn, K
    Friedman, A
    Johnson, P
    Keller, J
    BLOOD, 2004, 104 (11) : 446A - 446A